News Image
CNBCTV18

Caplin Point arm executes share purchase agreement to acquire entire stake in Triwin Pharma

Published on 04/06/2025 02:49 PM

Caplin Point arm executes share purchase agreement to acquire entire stake in Triwin PharmaTriwin Pharma was incorporated on February 12, 2019 and has reported no turnover in the last three years.By Shloka Badkar   June 4, 2025, 2:49:54 PM IST (Published)2 Min ReadCaplin Point Laboratories Ltd. on Wednesday, June 4, said its wholly-owned subsidiary Caplin Point Far East Ltd, Hong Kong, on Tuesday executed the share purchase agreement to acquire the entire stake in the Mexican company Triwin Pharma.

The current share capital of the company comprises 50,000 equity shares of one Mexican peso each. The company's turnover as on March 31, 2025 was nil, Caplin Point said in an exchange filing.

Triwin Pharma will be a related party of the company and other subsidiaries once the acquisition is complete. It will become a wholly-owned subsidiary of Caplin Point Far East Ltd. and a step-down subsidiary of Caplin Point Laboratories Ltd.

Triwin Pharma will be the front-end entity for Caplin Point in the Mexican market for tender sales, direct sales, marketing and distribution of products manufactured by the latter and its subsidiaries, the exchange filing stated.

The share purchase agreement was executed on June 3, 2025 and the acquisition will be completed once Caplin Point Far East Ltd. pays the consideration within 30 days.

Caplin Point Far East Ltd. will pay the entire consideration via normal banking channels.

Triwin Pharma was incorporated on February 12, 2019 and has reported no turnover in the last three years.

"The acquisition was a strategic decision, as it provides a local partner in Mexico — enabling participation in government tenders and also supporting the establishment of a stock-and-sale model, in line with our successful strategy in other Latin American Markets," the exchange filing stated.

Shares of Caplin Point are trading 0.3% lower after the announcement at ₹2,161.7. The stock is up 14% in the last one month.

Also Read: India Inc’s capex growth slows to a 4-year lowContinue ReadingCheck out our in-depth Market Coverage, Business News & get real-time Stock Market Updates on CNBC-TV18. Also, Watch our channels CNBC-TV18, CNBC Awaaz and CNBC Bajar Live on-the-go!TagsCaplin Point Laboratoriesshare market today